Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pleural Effusion | 2 | 2022 | 38 | 1.310 |
Why?
|
| Cecostomy | 1 | 2024 | 4 | 0.930 |
Why?
|
| Fecal Incontinence | 1 | 2022 | 12 | 0.820 |
Why?
|
| Empyema, Pleural | 1 | 2022 | 12 | 0.810 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2022 | 110 | 0.790 |
Why?
|
| Fibrinolytic Agents | 3 | 2022 | 125 | 0.780 |
Why?
|
| Postoperative Complications | 2 | 2024 | 1018 | 0.570 |
Why?
|
| Chest Tubes | 1 | 2016 | 21 | 0.550 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 137 | 0.510 |
Why?
|
| Pneumonia | 1 | 2016 | 117 | 0.510 |
Why?
|
| Radiology, Interventional | 3 | 2023 | 29 | 0.420 |
Why?
|
| Vascular Malformations | 2 | 2011 | 98 | 0.400 |
Why?
|
| Sclerotherapy | 2 | 2011 | 46 | 0.390 |
Why?
|
| Face | 1 | 2011 | 58 | 0.370 |
Why?
|
| Radiology Department, Hospital | 1 | 2009 | 11 | 0.340 |
Why?
|
| Videoconferencing | 1 | 2009 | 37 | 0.340 |
Why?
|
| User-Computer Interface | 1 | 2009 | 81 | 0.330 |
Why?
|
| Child, Preschool | 8 | 2024 | 3879 | 0.330 |
Why?
|
| Child | 8 | 2024 | 6849 | 0.330 |
Why?
|
| Vascular Surgical Procedures | 1 | 2011 | 164 | 0.320 |
Why?
|
| Information Dissemination | 1 | 2009 | 79 | 0.320 |
Why?
|
| Infant | 7 | 2024 | 3575 | 0.320 |
Why?
|
| Radiology | 1 | 2009 | 130 | 0.300 |
Why?
|
| Internet | 1 | 2009 | 261 | 0.290 |
Why?
|
| Thrombolytic Therapy | 2 | 2022 | 110 | 0.280 |
Why?
|
| Retrospective Studies | 4 | 2024 | 6124 | 0.250 |
Why?
|
| Adolescent | 6 | 2024 | 6417 | 0.230 |
Why?
|
| Treatment Outcome | 3 | 2024 | 5178 | 0.220 |
Why?
|
| Young Adult | 3 | 2022 | 4031 | 0.220 |
Why?
|
| Radiographic Image Enhancement | 1 | 2003 | 30 | 0.210 |
Why?
|
| Tibial Fractures | 1 | 2003 | 30 | 0.210 |
Why?
|
| Colostomy | 1 | 2022 | 11 | 0.200 |
Why?
|
| Humans | 14 | 2024 | 49929 | 0.190 |
Why?
|
| Physicians | 1 | 2023 | 229 | 0.170 |
Why?
|
| Pediatrics | 2 | 2017 | 280 | 0.170 |
Why?
|
| Female | 8 | 2024 | 26576 | 0.140 |
Why?
|
| Male | 7 | 2024 | 25454 | 0.140 |
Why?
|
| Drainage | 1 | 2016 | 79 | 0.130 |
Why?
|
| Quality of Life | 1 | 2022 | 838 | 0.130 |
Why?
|
| Prospective Studies | 1 | 2022 | 2345 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 638 | 0.120 |
Why?
|
| Veins | 2 | 2011 | 71 | 0.110 |
Why?
|
| Preoperative Care | 2 | 2011 | 167 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 2177 | 0.100 |
Why?
|
| Neck | 2 | 2010 | 99 | 0.100 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2011 | 40 | 0.100 |
Why?
|
| Blood Loss, Surgical | 1 | 2011 | 68 | 0.090 |
Why?
|
| Heart-Assist Devices | 1 | 2011 | 151 | 0.090 |
Why?
|
| Mouth | 1 | 2010 | 31 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2011 | 1526 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1129 | 0.070 |
Why?
|
| Length of Stay | 1 | 2011 | 624 | 0.070 |
Why?
|
| Time Factors | 2 | 2011 | 2891 | 0.070 |
Why?
|
| Hemangioma, Capillary | 1 | 2006 | 12 | 0.070 |
Why?
|
| Tongue | 1 | 2007 | 38 | 0.070 |
Why?
|
| Arteriovenous Malformations | 1 | 2007 | 68 | 0.060 |
Why?
|
| Popliteal Artery | 1 | 2004 | 27 | 0.060 |
Why?
|
| Arkansas | 1 | 2009 | 1990 | 0.060 |
Why?
|
| Albumins | 1 | 2003 | 30 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2004 | 74 | 0.050 |
Why?
|
| Ultrasonic Therapy | 1 | 2003 | 34 | 0.050 |
Why?
|
| Specialization | 1 | 2003 | 46 | 0.050 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2003 | 30 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2003 | 49 | 0.050 |
Why?
|
| Medicine | 1 | 2003 | 56 | 0.050 |
Why?
|
| Inpatients | 1 | 2023 | 193 | 0.050 |
Why?
|
| Contrast Media | 1 | 2003 | 186 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2006 | 487 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2023 | 285 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 858 | 0.040 |
Why?
|
| Thrombosis | 1 | 2003 | 249 | 0.040 |
Why?
|
| Adult | 3 | 2011 | 13356 | 0.040 |
Why?
|
| Internationality | 1 | 2017 | 41 | 0.040 |
Why?
|
| Middle Aged | 1 | 2011 | 12293 | 0.030 |
Why?
|
| Angiography | 2 | 2007 | 127 | 0.030 |
Why?
|
| Radiography | 1 | 2011 | 485 | 0.020 |
Why?
|
| Laser Therapy | 1 | 2010 | 84 | 0.020 |
Why?
|
| Mouth Floor | 1 | 2007 | 5 | 0.020 |
Why?
|
| Polyvinyl Alcohol | 1 | 2007 | 9 | 0.020 |
Why?
|
| Collateral Circulation | 1 | 2007 | 39 | 0.020 |
Why?
|
| Hemangioendothelioma | 1 | 2006 | 8 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2007 | 72 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2006 | 71 | 0.020 |
Why?
|
| Embolization, Therapeutic | 1 | 2007 | 85 | 0.020 |
Why?
|
| Sarcoma, Kaposi | 1 | 2006 | 75 | 0.020 |
Why?
|
| Hemangioma | 1 | 2006 | 83 | 0.020 |
Why?
|
| Recurrence | 1 | 2007 | 658 | 0.020 |
Why?
|
| Embolism | 1 | 2004 | 20 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 54 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 2004 | 95 | 0.010 |
Why?
|
| Aneurysm | 1 | 2004 | 33 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 820 | 0.010 |
Why?
|
| Pressure | 1 | 2004 | 105 | 0.010 |
Why?
|
| Leg | 1 | 2004 | 123 | 0.010 |
Why?
|
| Cysts | 1 | 2004 | 51 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2004 | 79 | 0.010 |
Why?
|
| Microspheres | 1 | 2003 | 26 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2004 | 102 | 0.010 |
Why?
|
| Ischemia | 1 | 2004 | 153 | 0.010 |
Why?
|
| Dogs | 1 | 2003 | 185 | 0.010 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2003 | 85 | 0.010 |
Why?
|
| Random Allocation | 1 | 2003 | 285 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2003 | 170 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2004 | 254 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 2729 | 0.010 |
Why?
|
| Aged | 1 | 2004 | 9449 | 0.010 |
Why?
|
| Animals | 1 | 2003 | 13100 | 0.000 |
Why?
|